Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish
Farmovs
In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19. 

The trial is expected to include more than 45 countries worldwide, including a number of South African sites. 

Farmovs

FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.   

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients. 

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.  FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.


News Archive

Krieket - Kovsies klop SUT
2005-01-31

Johan de Jager - Volksblad OFSKOON die spanne nie op volsterkte was nie, was die superligawedstryd tussen die Universteit van die Vrystaat (UV) en die Sentrale Universiteit vir Tegnologie, Vrystaat (SUT), Saterdag op Tokkiepark in Bloemfontein 'n toonbeeld van goeie klubkrieket. Die Kovsies het hul onoorwonne rekord behou toe hulle met ses paaltjies geseëvier het. Hulle het die wenteiken van 233 lopies in die 48ste boulbeurt oortref. Die voormalige kaptein Gerald Fourie (95 nun) het die aanslag gelei, terwyl die wenspan se Ryan McLaren (2/46 en 46) 'n veelsydige vertoning gelewer het. McLaren het hom op 'n driekuns bevind toe hy die laaste twee paaltjies ingeoes en toe byna 'n vyftigtal gemoker het. Die tuisspan het goed begin. Hy het egter ses paaltjies in die laaste tien boulbeurte verloor. Die Kovsies het mooi herstel nadat hulle 24/2 gehad het. Die tuisspan se Dewald Pretorius het met 2/11 ná agt boulbeurte gespog . Die wedstryd op CBCOB se veld tussen die tuisspan en SUT II is ná 'n ruk se spel aanvanklik afgelas omdat toestande as te gevaarlik bestempel is, maar is later die middag hervat en oor 25 boulbeurte aan 'n kant beslis . SUT II is vir 82 lopies uitgehaal, waarna CBCOB die wenlopies behaal het met nog vier paaltjies staande . Schoemanpark was in Mangaung met vyf paaltjies aan die wenkant teen Rocklands, terwyl Polisie sy tweede agtereenvolgende nederlaag in die tweede ronde gely het nadat die Peshawars hom naelskraap met 'n paaltjie op die UV-ovaal geklop het. Die tuisspan se Ferdi Botha (116) se honderdtal het gehelp dat die Peshawars die wedstryd met nog twee aflewerings oor kon wen nadat Polisie vroeër 221/8 aangeteken het. Die beknopte telkaarte is: SUT 232 (I. O'Neill 37, H. von Rauenstein 67, G. Liebenberg 26, G. McLaren 28; C. Deacon 2/47, R. McLaren 2/46, G. Perry 2/29, C. Ingram 2/44); UV 234/4 (R. McLaren 46, G. Fourie 95 nun, C. Linde 27, E. Weirich 27 nun; D. Pretorius 2/29). Kovsies wen met ses paaltjies. SUT II 82 (J. Labuscagne 21, A. van Deventer 16; J. Chemaly 3/11, M. Mashimbyi 2/7, J. Malao 2/19); CBCOB 84/6 (M. Mashimbyi 22, T. van der Westhuizen 21, P. Stander 21; R. Daniël 2/6, R. Wessels 2/17). CBCOB wen met vier paaltjies. Rocklands 107 (D. Makopanele 22); Schoemanpark 108/5 (J. Smith 37; N. Sefuthi 2/14). Schoemanpark wen met vyf paaltjies. Polisie 221/8 (W. Nel 86, B. Hector 62; N. de Bruin 4/49, J. Mostert 1/19, R. de Kock 2/50); Peshawars 222/9 (F. Botha 116, J. Mostert 26; W. Thies 3/30, E. van Niekerk 3/43). Peshawars wen met 'n paaltjie.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept